Ayumi Sugiura

Nakano, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Biochemical and Plasma Lipid Responses to Pemafibrate in Patients With Primary Biliary Cholangitis and Dyslipidemia: A Four-Year Analysis.

Biochemical and Plasma Lipid Responses to Pemafibrate in Patients With Primary Biliary Cholangitis and Dyslipidemia: A Four-Year Analysis.

Journal: Cureus

Published: April 29, 2025

Spontaneous rupture of hepatocellular carcinoma in Fontan-associated liver disease with fatal outcome: case report and literature review.

Spontaneous rupture of hepatocellular carcinoma in Fontan-associated liver disease with fatal outcome: case report and literature review.

Journal: Clinical journal of gastroenterology

Published: February 10, 2025

Hormone replacement therapy for steatotic liver management after surgical menopause.

Hormone replacement therapy for steatotic liver management after surgical menopause.

Journal: Clinical journal of gastroenterology

Published: October 16, 2024

Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.

Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.

Journal: Journal of viral hepatitis

Published: August 26, 2024

Serum Autotaxin Levels Predict Liver-Related Events in Patients With Primary Biliary Cholangitis: A Long-Term Multicenter Observational Study.

Serum Autotaxin Levels Predict Liver-Related Events in Patients With Primary Biliary Cholangitis: A Long-Term Multicenter Observational Study.

Journal: Clinical and translational gastroenterology

Published: July 29, 2024

Long-Term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD.

Long-Term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD.

Journal: Frontiers in endocrinology

Published: October 28, 2023

Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study.

Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study.

Journal: Cancers

Published: October 02, 2023

Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease.

Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease.

Journal: Communications medicine

Published: September 26, 2023

Pyogenic liver abscess associated with Klebsiella oxytoca: Mimicking invasive liver abscess syndrome.

Pyogenic liver abscess associated with Klebsiella oxytoca: Mimicking invasive liver abscess syndrome.

Journal: Heliyon

Published: April 17, 2023

Symptom-based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease.

Symptom-based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: March 24, 2023

Kinetics of serum O-glycosylated M-hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients.

Kinetics of serum O-glycosylated M-hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients.

Journal: Journal of viral hepatitis

Published: February 14, 2023

HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.

HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.

Journal: Human immunology

Published: February 13, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026